Comparing Medial and Lateral Dissection Approaches to the Recurrent Laryngeal Nerve During a Thyroidectomy

ConditionThyroidectomy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorOleksandr Butskiy

About this trial

The goal of this interventional study is to compare the effectiveness of two surgical approaches in identifying the recurrent laryngeal nerve (RLN) during thyroidectomy. The main questions it aims to answer are:

How does each approach affect the length of hospital stay? How does each approach affect the number of adverse events that occur during surgery? How does each approach affect vocal cord function after surgery?

Researchers will compare the new medial approach to the standard lateral approach to evaluate its effectiveness.

Participants scheduled to undergo thyroidectomy surgery will be randomly assigned to one of these approaches after informed consent is obtained. Data will be collected during and after the surgery by a research assistant.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

All patients undergoing a total thyroidectomy or hemithyroidectomy under the care of the participating surgeons

Disqualifiers

Age less than 19 years old

Previous thyroid or parathyroid surgery, substernal goiter, preoperative vocal cord palsy (VCP)

Evidence of lateral or central neck lymph node metastases

Intentional iatrogenic transection of the RLN due to tumor invasion

Trial design

Design model

Parallel

Treatments tested in this trial

  • Approach to RLN during Thyroidectomy

    Procedure/Surgery

    Medial vs Lateral Approach to RLN during thyroidectomy

Treatment groups

430 Participants
are divided into 2 treatment groups
Group A: Medial ApproachExperimental treatment 1 intervention
Group B: Lateral ApproachActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Intraoperative injury to the RLN

1. LOS - as defined by a decline of amplitude to \<100uV as measured by CIONM 2. Combined adverse events - an event wherein both 50% reduction in EMG amplitude and 10% latency are observed on CIONM

Time frame
Intraoperatively
2

Temporary vocal cord palsy as defined endoscopically

Time frame
2 weeks postoperatively

Secondary outcomes

1

Hypoparathyroidism

1. Temporary hypocalcemia - ionized calcium \<1.0 mmol/L on post operative day 1 OR any requirement for calcium AND vitamin D supplementation for 6 months or less post surgery 2. Permanent hypocalcemia - any hypocalcemia requiring calcium AND vitamin D supplementation for over 6 months post surgery

Time frame
6 months postoperatively
2

Postoperative hematoma requiring evacuation in the operating room

Yes/No

Time frame
Immediately following surgery
3

Postoperative hematoma not requiring evacuation in the operating room

Yes/No

Time frame
Immediately following surgery
4

Skin to skin operative time (minutes)

Time frame
Intraoperatively

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Oleksandr Butskiy

Lead sponsor

University of British Columbia

Sponsor institution

Inomed

Collaborator

This trial is not recruiting at the moment. You can still explore other options: